{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:48:07Z","timestamp":1780710487132,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Technology Innovation Agency (TIA) Tshwane Animal Health Cluster","award":["TAHC12-00013"],"award-info":[{"award-number":["TAHC12-00013"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.08.042","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T07:55:07Z","timestamp":1566892507000},"page":"6068-6075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep"],"prefix":"10.1016","volume":"37","author":[{"given":"Nobalanda B.","family":"Mokoena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boitumelo","family":"Moetlhoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria A.","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sipho","family":"Mamputha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vusi S.","family":"Dibakwane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsepo L.","family":"Tsekoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"O'Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.08.042_b0005","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2014.09.066","article-title":"Strong protective induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle","volume":"32","author":"Anderson","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.042_b0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/hv.22218","article-title":"Plant-derived virus-like particles as vaccines","volume":"9","author":"Chen","year":"2013","journal-title":"Human Vaccines Immunotherap"},{"key":"10.1016\/j.vaccine.2019.08.042_b0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vetimm.2012.04.026","article-title":"Virus-like particles: The new frontier of vaccinesor animal viral infections","volume":"148","author":"Crisci","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.08.042_b0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13567-018-0600-4","article-title":"Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses","volume":"49","author":"Dennis","year":"2018","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.08.042_b0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.11.013","article-title":"Recombinant vaccines against bluetongue virus","volume":"182","author":"Calvo-Pinilla","year":"2014","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.042_b0030","first-page":"616","article-title":"The use of vaccination in the control of bluetongue in southern Africa","volume":"40","author":"Dungu","year":"2004","journal-title":"Veterinaria Italiana"},{"key":"10.1016\/j.vaccine.2019.08.042_b0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1874318808002010130","article-title":"Attenuated live Bluetongue virus vaccine protects sheep from challenge with the European BTV-8","volume":"2","author":"Dungu","year":"2008","journal-title":"Open Vet Sci J"},{"key":"10.1016\/j.vaccine.2019.08.042_b0040","unstructured":"Dungu B, von Teichmann B, Louw I. Inactivated live-attenuated Bluetongue virus vaccine WO 2009\/128043 A1; 2009."},{"key":"10.1016\/j.vaccine.2019.08.042_b0045","unstructured":"Fay P, Attouri H, Mohd-Jafaar F, Batten C, Nomikou K, Daly J, et al. Evidence of a protective immune response using transiently expressed Bluetongue protein, VP2, from a Plant-based system and cross-reactive studies. In: 12th International dsRNA Virus Symposium, Goa, India, 6-10 October 2015."},{"key":"10.1016\/j.vaccine.2019.08.042_b0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.vaccine.2014.12.003","article-title":"Application of Bluetongue disabled infectious single animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimaeric VP2","volume":"33","author":"Feenstra","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.042_b0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/1040841X.2016.1186005","article-title":"Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations","volume":"43","author":"Feenstra","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.042_b0060","first-page":"317","article-title":"Plaque formation by bluetongue virus","volume":"34","author":"Howell","year":"1967","journal-title":"Onderstepoort Vet Res"},{"key":"10.1016\/j.vaccine.2019.08.042_b0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13567-018-0556-4","article-title":"Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions","volume":"49","author":"Martinelle","year":"2018","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2019.08.042_b0070","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.vaccine.2014.05.056","article-title":"Immunization with bacterial expressed VP2 and VP5 of bluetongue virus (BTV) protect alpha\/beta interferonreceptor knock-out (IFNAR(-\/-) mice from homologous lethal challenge","volume":"32","author":"Mohd-Jaafar","year":"2014","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2019.08.042_b0075","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1128\/JVI.78.15.8059-8067.2004","article-title":"Interactions between the Inner and Outer capsids of Bluetongue virus","volume":"78","author":"Nason","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.08.042_b0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/icb.1993.44","article-title":"Genetically engineered multi-component virus-like particles as veterinary vaccines","volume":"71","author":"Pearson","year":"1993","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2019.08.042_b0085","first-page":"30","article-title":"Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes","volume":"45","author":"Rojas","year":"2014","journal-title":"BioMed Central, Vet Res"},{"issue":"2012","key":"10.1016\/j.vaccine.2019.08.042_b0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-12-404634-4.00009-7","article-title":"Using a virus-derived system to manipulate plant natural product biosynthesis pathways","volume":"517","author":"Sainsbury","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2019.08.042_b0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cimid.2007.07.006","article-title":"Vaccines against bluetongue in Europe","volume":"31","author":"Savini","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.042_b0100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/JVI.02266-12","article-title":"Reassortment between two serologically unrelated Bluetongue virus strains is flexible and can involve any genome segment","volume":"87","author":"Shaw","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.08.042_b0105","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"Shevchenko","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2019.08.042_b0110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1467-7652.2008.00330.x","article-title":"Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogenous human-like N-glycan structure","volume":"6","author":"Strasser","year":"2008","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2019.08.042_b0115","first-page":"1","article-title":"A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles","author":"Thuenemann","year":"2013","journal-title":"Plant Biotechnol J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.042_b0120","first-page":"1","article-title":"Complete genome sequence of five Bluetongue virus (BTV) vaccine strains from a commercially live attenuated vaccine, a BTV-4 field strain from South Africa, and a reassortant strain isolated from experimentally vaccinated cattle","volume":"4","author":"Van den Bergh","year":"2016","journal-title":"Am Soc Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.042_b0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.btre.2015.12.001","article-title":"Transient Bluetongue virus serotype 8 capsid protein expression in Nicotiana benthamiana","volume":"9","author":"Van Zyl","year":"2016","journal-title":"Biotechnol Reports"},{"key":"10.1016\/j.vaccine.2019.08.042_b0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11259-015-9643-4","article-title":"Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine","volume":"39","author":"Zhugunissov","year":"2015","journal-title":"Vet Res Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.042_b0135","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4102\/jsava.v85i1.1041","article-title":"Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep","volume":"85","author":"Zulu","year":"2014","journal-title":"J S Afr Vet Assoc"},{"key":"10.1016\/j.vaccine.2019.08.042_b9000","unstructured":"World Organisation for Animal Health (OIE), 2014 https:\/\/www.oie.int\/standard-setting\/terrestrial-manual\/access-online\/"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:57Z","timestamp":1759401237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19311065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":28,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19311065"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}